The Biden-Harris Administration recently announced various actions to lower healthcare and prescription drug costs. In one action, the National Institute of Standards and Technology (NIST) released in December 2023 a draft...more
2/2/2024
/ Bayh-Dole Act ,
Biden Administration ,
Comment Period ,
Disclosure Requirements ,
Drug Pricing ,
Federal Funding ,
Healthcare ,
Healthcare Reform ,
Innovation Patent ,
Inventions ,
Licensees ,
March-in-Rights ,
NIST ,
Patent Applications ,
Patent Ownership ,
Patents ,
Pharmaceutical Industry ,
Prescription Drugs ,
Public Comment
This client alert examines intellectual property proposals in the Trans-Pacific Partnership from the perspective of biotechnology, pharmaceutical, and chemical industries.
On November 5, 2015, the U.S. trade...more